Dexetimide
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | N04AA08 (WHO) |
| Identifiers | |
| |
| CAS Number |
21888-98-2 |
| PubChem (CID) | 30843 |
| IUPHAR/BPS | 354 |
| DrugBank |
DB08997 |
| ChemSpider |
28615 |
| UNII |
43477QYX3D |
| KEGG |
D03711 |
| ChEMBL |
CHEMBL1908364 |
| Chemical and physical data | |
| Formula | C23H26N2O2 |
| Molar mass | 362.465 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Dexetimide (brand name Tremblex) is a piperidine anticholinergic. It is a muscarinic antagonist that is used to treat drug induced parkinsonism. Dexetimide was discovered at Janssen Pharmaceutica in 1968.[1][2]
References
- ↑ Dom, R.; Van Lommel, R.; Baro, F. (1971). "A quantitative study of neuroleptic-induced extrapyramidal symptoms and their response to dexetimide, a potent and long-acting antiparkinsonian agent". Acta Psychiatrica Scandinavica. 47 (4): 399–410. doi:10.1111/j.1600-0447.1971.tb03697.x. PMID 4947805.
- ↑ Huygens, H.; Vereecken, J. L.; Tanghe, A. (1973). "Dexetimide (R 16470) in the control of neuroleptic-induced extrapyramidal side-effects. Its prophylactic value and duration of action". Psychiatria, neurologia, neurochirurgia. 76 (4): 251–259. PMID 4581374.
This article is issued from Wikipedia - version of the 4/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
